Literature DB >> 21613790

Polymorphisms in the catechol-o-methyltransferase gene and delirium in the elderly.

Barbara C van Munster1, Frank Baas, Michael W Tanck, Sophia E J A de Rooij.   

Abstract

BACKGROUND/AIMS: Catechol-O-methyltransferase, encoded by the COMT gene, is one of the enzymes that degrade dopamine. The aim of this study was to investigate whether polymorphisms in the COMT gene were associated with delirium.
METHODS: Patients aged 65 years and older, acutely admitted to the medical department or to the surgical department following hip fracture, were included. rs4680, rs4818, and rs6269 were genotyped.
RESULTS: Delirious patients were older, and more frequently had preexisting functional or cognitive impairment (p < 0.001). Polymorphisms in the COMT gene were not associated with the development of delirium.
CONCLUSION: Although the COMT gene is a promising candidate gene for delirium in the elderly, functional genetic variations were not associated with delirium.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613790     DOI: 10.1159/000327353

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  3 in total

1.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

2.  The Association Between C-Reactive Protein and Postoperative Delirium Differs by Catechol-O-Methyltransferase Genotype.

Authors:  Sarinnapha M Vasunilashorn; Long H Ngo; Richard N Jones; Sharon K Inouye; Kathryn T Hall; Jacqueline Gallagher; Simon T Dillon; Zhongcong Xie; Towia A Libermann; Edward R Marcantonio
Journal:  Am J Geriatr Psychiatry       Date:  2018-09-14       Impact factor: 4.105

3.  The complex interaction of genetics and delirium: a systematic review and meta-analysis.

Authors:  Esteban Sepulveda; Dimitrios Adamis; Jose G Franco; David Meagher; Selena Aranda; Elisabet Vilella
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-29       Impact factor: 5.270

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.